ADMA Biologics - ADMA Company Short-Term Debt

Graphic logo of ADMA Biologics (ADMA)

ADMA Biologics dominates pricing due to its life-saving drugs and full control over the supply chain. The organization's short-term debt demonstrates liability inertia, with the current level equal to 0.00. Revenues are based on the sale of immunoglobulins and plasma. However, narrow specialization in a single segment creates significant regulatory risks and financial vulnerability.

ADMA (ADMA Biologics Inc) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

ADMA Corp - analytical breakdowns and key metrics (ADMA)

- price and consensus price forecast:
Price Chart ADMA Biologics, Inc.|ADMA - Fair Value Consensus
- market capitalization data:
Market Value ADMA Biologics, Inc.|ADMA - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share ADMA Biologics|ADMA - Book Capitalization|Market Cap to Net Assets Ratio admabiologics.com|ADMA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital ADMA Biologics|ADMA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity ADMA Biologics|ADMA - Company Total Debt|Debt to Book Capitalization Ratio ADMA Biologics, Inc.|ADMA - Company Long-Term Liabilities|Company Current Liabilities ADMA Biologics
Fundamental company valuation:ADMA Biologics, Inc. - ADMA
Product sample of ADMA Biologics

Investors are verifying the issuer's solvency by comparing current short-term liabilities with liquid asset volumes to assess default risks. By analyzing short-term debt statistics, one can evaluate the ability of ADMA Biologics (ADMA) to finance plasma procurement from external suppliers and localize supply chains, where a reduction in debt load confirms the company's transition toward a more autonomous and sustainable operating model.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|Protagonist Corp (PTGX) - Company Current Liabilities|IMVT (Immunovant, Inc.) - Company Short-Term Debts|Company Short-Term Debts kiniksa.com (KNSA)|Grifols (GRFS) - Company Current Liabilities|Company Short-Term Loans and Borrowings Adaptive Biotech (ADPT)|Company Short-Term Debts CLDX|Aurinia Corp - Short-Term Debt Volume|BCRX: Company Short-Term Debt|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Current Liabilities|Company Short-Term Debts TRML|Company Short-Term Debt Precigen, Inc. PGEN|Company Short-Term Indebtedness pharming.com (PHAR)|NKTR: Company Short-Term Debts|Short-Term Debt Upstream Bio, Inc. UPB|Zenas Biopharma, Inc. - Company Short-Term Debts|IMNM - Company Short-Term Debts|Company Short-Term Debts Gossamer Bio, Inc.|KALV (kalvista.com) - Company Short-Term Indebtedness|Company Short-Term Debt SEPN|Company Current Liabilities Pieris Pharma|Company Short-Term Debts SVRA|Company Short-Term Debts Rigel Corp RIGL|Company Current Liabilities AnaptysBio, Inc.|Company Short-Term Loans and Borrowings astriatx.com ATXS|ENGN - Company Short-Term Debts|RAPT - Company Short-Term Debt|aerovatetx.com - Company Short-Term Debts|ACRS (Aclaris Therapeutics, Inc) - Short-Term Debt Volume|Company Short-Term Debt KYTX (Kyverna Therapeutics)|Short-Term Debt TLSA|Company Short-Term Debt Cabaletta Bio (CABA)|Company Short-Term Debt VTYX (Ventyx Biosciences Inc.)|THTX: Company Short-Term Debt|Short-Term Debt Avalo Therapeutics Inc AVTX|Company Short-Term Debts ELDN|AGEN - Short-Term Indebtedness|Climb Bio - Company Short-Term Debts|zurabio.com (ZURA) - Short-Term Debt Volume|Company Short-Term Debts ATYR|Company Current Liabilities ADAG|IMA (ImageneBio Inc) - Company Short-Term Debt|Short-Term Debt Volume shattucklabs.com (STTK)|Company Short-Term Debts EQ (Equillium)|Company Short-Term Debts Connect Biopharma Holdings CNTB|Immunic Inc (IMUX) - Company Short-Term Debts|ATRA: Company Short-Term Indebtedness|IFRX (inflarx.de) - Company Short-Term Debt|x4pharma.com (XFOR) - Company Current Liabilities|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Short-Term Debts CELU|INMB - Company Short-Term Debt|Current Liabilities Barinthus Biotherapeutics Corp (BRNS)|Company Short-Term Debts Kezar Life Sciences|Company Short-Term Loans and Borrowings sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Company Short-Term Debts|ENLV: Company Short-Term Debts|Company Short-Term Debt q32bio.com QTTB|GOVX (GeoVax Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debt EDSA|Company Current Liabilities ibioinc.com|Company Short-Term Debts CARM|Company Short-Term Debts XTL Biopharmaceuticals Ltd XTLB|Company Current Liabilities Bolt Biotherapeutics, Inc.|Company Short-Term Loans and Borrowings HCW Biologics, Inc. HCWB|Company Short-Term Debts APVO (Aptevo)|AIM: Short-Term Debt Volume|ADTX (aditxt.com) - Company Short-Term Debt|GRI (GRI Bio Inc) - Company Current Liabilities|Company Short-Term Debt XRTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Current Liabilities REVB|Company Short-Term Debts INDP (indaptusrx.com)|SCNI - Company Short-Term Debt|Company Short-Term Indebtedness CalciMedica Inc CALI|AFMD (Affimed Therapeutics) - Company Short-Term Debts|ALLK - Short-Term Debt|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debts iTeos Therapeutics, Inc. (ITOS)|Company Short-Term Indebtedness OCEA|Company Short-Term Debt TCBP (TC BioPharm (Holdings) PLC)|Company Current Liabilities Third Harmonic Bio Inc (THRD)